News Pfizer cholesterol drug succeeds in two late stage trials Pfizer's bococizumab cholesterol drug has met primary endpoint in two phase 3 trials, part of a series of six late-stage studies.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Pfizer's antibody drug trial misses key survival target in A... Inotuzumab ozogamicin missed one of two endpoints in trial.
News Pfizer to work with IBM on Parkinson’s disease wearable American pharma giant Pfizer has enlisted the help of technology multinational IBM in an ambitious bid to transform both care and treatment for Parkinson's disease.
Articles Pharma news round-up: Pfizer-Allergan merger scrapped, Gilea... A round-up of this week's top pharma and healthcare news – plus reaction from social media. Marco Ricci reports.
News Pfizer to end $160bn Allergan merger after US tax changes US Treasury move means mega-merger no longer feasible
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
